Aso Y, Ushiyama T, Tajima A, Suzuki K, Ohtawara Y, Ohta N, Ohmi Y, Hata M, Masuda H, Kanbayashi T
Nihon Hinyokika Gakkai Zasshi. 1989 Jan;80(1):69-73. doi: 10.5980/jpnjurol1989.80.69.
During about 10 years from November, 1977 to March, 1987, 46 patients with renal pelvic and ureteral tumors were treated at the Department of Urology, Hamamatsu University School of Medicine and the affiliated hospitals. There were 34 males and 12 females with the highest age incidence in the seventies. Histologically, 44 transitional cell carcinomas and 2 squamous cell carcinomas were found. Of the 44 transitional cell carcinomas, 1 was Tis; 13 T1, 2 T2, 8 T3, 15 M+ (with metastatic lesion), and 5 TX. As to grading, 1 was G1; 24 G2, 15 G3, and 4 GX. Staging was correlated with grading. The 5-year survival rates (Kaplan-Meier's method) were 37% in patients with transitional cell carcinoma. Among patients with transitional cell carcinoma, the 5-year survival rate was 43% for G2 and 42% for G3. As to staging, the 5-year survival rates were 71% and 46% in patients with stage of T1 and T3, respectively. No patient with M+ survived longer than 4 years. The 5-year survival rates were 38% and 34% in renal pelvic tumors (24 cases) and ureteral tumors (20 cases), respectively. As to the treatments, the 5-year survival rates after curable treatment (24 cases) and non-curable treatment (20 cases) were 63% and 7%, respectively.
1977年11月至1987年3月的约10年间，静冈大学医学院泌尿外科及其附属医院共收治了46例肾盂及输尿管肿瘤患者。其中男性34例，女性12例，发病年龄高峰在70岁。组织学检查发现44例移行细胞癌和2例鳞状细胞癌。在44例移行细胞癌中，Tis期1例；T1期13例，T2期2例，T3期8例，M+（伴有转移灶）15例，TX期5例。分级方面，G1期1例；G2期24例，G3期15例，GX期4例。分期与分级相关。移行细胞癌患者的5年生存率（Kaplan-Meier法）为37%。在移行细胞癌患者中，G2期的5年生存率为43%，G3期为42%。分期方面，T1期和T3期患者的5年生存率分别为71%和46%。没有M+期患者存活超过4年。肾盂肿瘤（24例）和输尿管肿瘤（20例）的5年生存率分别为38%和34%。治疗方面，可治愈治疗（24例）和不可治愈治疗（20例）后的5年生存率分别为63%和7%。
